NCT00074776View on ClinicalTrials.gov

Acute Treatment of Bipolar II Depression

PHASE3CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Bipolar Disorder
Interventions
DRUG

Lithium

Participants will receive lithium.

DRUG

Lamotrigine

Participants will receive lamotrigine.

Trial Locations (1)

75390-9121

University of Texas Southwestern Medical Center at Dallas, Dallas

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Stanford University

OTHER

NCT00074776 - Acute Treatment of Bipolar II Depression | Biotech Hunter | Biotech Hunter